Overview
Red Queen Bio, based in Boston, United States, has raised $15M in a Seed round on Nov 13, 2025, with participation from OpenAI Startup Fund. The company aI biosecurity company. The round will be used to accelerate product development, expand the team, and scale go-to-market operations.
Operating in the biotechnology research sector, Red Queen Bio is positioned to capitalize on growing demand for innovative solutions in this space. The company was founded in 2025 by Nikolai Eroshenko. Nikolai brings deep domain expertise and a track record of execution that attracted investor confidence in this round. With fresh capital, the company is expected to invest heavily in R&D and talent acquisition, signaling a period of aggressive growth ahead.
Market Outlook
With $15M now on the balance sheet, Red Queen Bio enters a new phase of growth that typically involves rapid hiring, technology upgrades, and vendor evaluations. For sales professionals and service providers, this represents a prime opportunity to engage while budget allocation decisions are being made and the team is actively building out its operational infrastructure.
Why contact Red Queen Bio now
With $15M in fresh capital from Seed, Red Queen Bio is entering a rapid growth phase. Post-funding startups typically increase headcount by 30-50% and begin evaluating new tools and services immediately. The founders and decision-makers are actively taking meetings right now — making this the perfect time to connect before their calendars fill up.
Founders & Contacts
Investors
Company Facts
| Company | Red Queen Bio |
| Amount Raised | $15M |
| Funding Round | Seed |
| Date Raised | Nov 13, 2025 |
| Founded | 2025 |
| Industry | Biotechnology Research |
| Founders | Nikolai Eroshenko |
| HQ Location | Boston, United States |
Get Verified Founder Emails
Access verified email addresses and contact details for Red Queen Bio's founders and thousands of other funded startups.
Start Free Trial